{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T18:42:24Z","timestamp":1772822544313,"version":"3.50.1"},"reference-count":120,"publisher":"Becaris Publishing Limited","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J. Comp. Eff. Res."],"published-print":{"date-parts":[[2026,3]]},"abstract":"<jats:p>\n                    <jats:bold>Aim:<\/jats:bold>\n                    To investigate the data sources available in Mexico for real-world research.\n                    <jats:bold>Materials &amp; methods:<\/jats:bold>\n                    A systematic literature review on PubMed, EMBASE and VHL using a combination of controlled vocabulary and keywords for the concepts of electronic health records, epidemiologic studies and Mexico was performed.\n                    <jats:bold>Results:<\/jats:bold>\n                    A total of 331 articles and 89 conference abstracts reporting real-world studies were identified. These included 320 data sources: 142 unique named databases, 172 unnamed databases from specified providers, and 26 electronic medical record datasets. The main data sources came from healthcare institutions (35%), followed by government agencies (26%). The most frequent database design corresponded to surveys (34%) and disease registries (20%). Most databases included cohort studies (43%), population-based (25%) and cross-sectional studies (18%). Specific diagnostic tests (28%), access (22%) and pharmacological treatment (21%) were the most common issues analyzed in databases at patient-level data. Neoplasms, cardiac disorders and infections\/infestations were the most common therapeutic areas analyzed in databases.\n                    <jats:bold>Conclusion:<\/jats:bold>\n                    In Mexico, the use of databases has increased, driven by governmental and nongovernmental organisations and companies. However, further efforts are still needed to improve the quality and knowledge of real-world evidence.\n                  <\/jats:p>","DOI":"10.57264\/cer-2025-0160","type":"journal-article","created":{"date-parts":[[2026,3,5]],"date-time":"2026-03-05T15:47:37Z","timestamp":1772725657000},"source":"Crossref","is-referenced-by-count":0,"title":["Availability of secondary healthcare data for conducting pharmacoepidemiology studies in Mexico: a systematic review"],"prefix":"10.57264","volume":"15","author":[{"given":"Carla","family":"Ceballos Ruiz","sequence":"first","affiliation":[{"name":"Medical Affairs Department, Bayer, M\u00e9xico"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Angelica","family":"Navarro","sequence":"additional","affiliation":[{"name":"Medical Affairs Department, Bayer, M\u00e9xico"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"36897","reference":[{"issue":"1","key":"e_1_3_6_3_2","first-page":"31","article-title":"The significance of clinical trials","volume":"1","author":"Novitzke JM","year":"2008","unstructured":"Novitzke JM. The significance of clinical trials. J. Vasc. Interv. Neurol. 1(1), 31 (2008).","journal-title":"J. Vasc. Interv. Neurol."},{"issue":"5","key":"e_1_3_6_4_2","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1002\/cpt.2083","article-title":"Randomized controlled trials versus real world evidence: neither magic nor myth","volume":"109","author":"Eichler HG","year":"2021","unstructured":"Eichler HG, Pignatti F, Schwarzer-Daum B Randomized controlled trials versus real world evidence: neither magic nor myth. Clin. Pharmacol. Ther. 109(5), 1212\u20131218 (2021).","journal-title":"Clin. Pharmacol. Ther."},{"issue":"7","key":"e_1_3_6_5_2","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1056\/NEJMsb1901642","article-title":"The magic of randomization versus the myth of real-world evidence","volume":"382","author":"Collins R","year":"2020","unstructured":"Collins R, Bowman L, Landray M, Peto R. The magic of randomization versus the myth of real-world evidence. N. Engl. J. Med. 382(7), 674\u2013678 (2020).","journal-title":"N. Engl. J. Med."},{"issue":"5","key":"e_1_3_6_6_2","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1111\/j.1524-4733.2007.00186.x","article-title":"Using real-world data for coverage and payment decisions: the ISPOR real-world data task force report","volume":"10","author":"Garrison LP","year":"2007","unstructured":"Garrison LP, Neumann PJ, Erickson P, Marshall D, Mullins CD. Using real-world data for coverage and payment decisions: the ISPOR real-world data task force report. Value Health 10(5), 326\u2013335 (2007).","journal-title":"Value Health"},{"issue":"1","key":"e_1_3_6_7_2","doi-asserted-by":"crossref","first-page":"e0000003","DOI":"10.1371\/journal.pdig.0000003","article-title":"Best practices in the real-world data life cycle","volume":"1","author":"Zhang J","year":"2022","unstructured":"Zhang J, Symons J, Agapow P Best practices in the real-world data life cycle. PLoS Digit. Health 1(1), e0000003 (2022).","journal-title":"PLoS Digit. Health"},{"issue":"8","key":"e_1_3_6_8_2","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1111\/j.1524-4733.2009.00605.x","article-title":"The ISPOR good practices for quality improvement of cost-effectiveness research task force report","volume":"12","author":"McGhan WF","year":"2009","unstructured":"McGhan WF, Al M, Doshi JA, Kamae I, Marx SE, Rindress D. The ISPOR good practices for quality improvement of cost-effectiveness research task force report. Value Health 12(8), 1086\u20131099 (2009).","journal-title":"Value Health"},{"issue":"3","key":"e_1_3_6_9_2","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1002\/pds.5404","article-title":"Data sources for drug utilization research in Latin American countries-a cross-national study: DASDUR-LATAM study","volume":"31","author":"Lopes LC","year":"2022","unstructured":"Lopes LC, Salas M, Osorio-de-Castro CGS Data sources for drug utilization research in Latin American countries-a cross-national study: DASDUR-LATAM study. Pharmacoepidemiol. Drug Saf. 31(3), 343\u2013352 (2022).","journal-title":"Pharmacoepidemiol. Drug Saf."},{"key":"e_1_3_6_10_2","doi-asserted-by":"publisher","DOI":"10.1002\/pds.4989"},{"key":"e_1_3_6_11_2","unstructured":"European Medicines Agency (EMA). Guideline on good pharmacovigilance practices (GVP) - Module VIII - Post-authorization safety studies (Rev. 3) EMA\/813938\/2011 Rev 3. First published 25 June 2012; last updated 12 October 2017. Available at: https:\/\/www.ema.europa.eu\/en\/documents\/scientific-guideline\/guideline-good-pharmacovigilance-practices-gvp-module-viii-post-authorisation-safety-studies-rev-3_en.pdf"},{"issue":"8","key":"e_1_3_6_12_2","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1111\/j.1524-4733.2009.00653.x","article-title":"ISPOR Health Policy Council proposed Good Research Practices for comparative effectiveness research: benefit or harm?","volume":"12","author":"St\u00fcrmer T","year":"2009","unstructured":"St\u00fcrmer T, Carey T, Poole C. ISPOR Health Policy Council proposed Good Research Practices for comparative effectiveness research: benefit or harm? Value Health 12(8), 1042\u20131043 (2009).","journal-title":"Value Health"},{"issue":"12","key":"e_1_3_6_13_2","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1002\/pds.4076","article-title":"Probabilistic bias analysis in pharmacoepidemiology and comparative effectiveness research: a systematic review","volume":"25","author":"Hunnicutt JN","year":"2016","unstructured":"Hunnicutt JN, Ulbricht CM, Chrysanthopoulou SA, Lapane KL. Probabilistic bias analysis in pharmacoepidemiology and comparative effectiveness research: a systematic review. Pharmacoepidemiol. Drug Saf. 25(12), 1343\u20131353 (2016).","journal-title":"Pharmacoepidemiol. Drug Saf."},{"issue":"2","key":"e_1_3_6_14_2","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1111\/1468-0009.12555","article-title":"A road map to rigor and relevance in pharmaceutical policy research","volume":"100","author":"Donohue JM","year":"2022","unstructured":"Donohue JM. A road map to rigor and relevance in pharmaceutical policy research. Milbank Q. 100(2), 341\u2013344 (2022).","journal-title":"Milbank Q."},{"issue":"2","key":"e_1_3_6_15_2","doi-asserted-by":"crossref","first-page":"217","DOI":"10.2307\/3350399","article-title":"A critical analysis of studies of state drug reimbursement policies: research in need of discipline","volume":"71","author":"Soumerai SB","year":"1993","unstructured":"Soumerai SB, Ross-Degnan D, Fortess EE, Abelson J. A critical analysis of studies of state drug reimbursement policies: research in need of discipline. Milbank Q. 71(2), 217\u2013252 (1993).","journal-title":"Milbank Q."},{"key":"e_1_3_6_16_2","doi-asserted-by":"crossref","first-page":"111","DOI":"10.12688\/f1000research.13585.2","article-title":"Real world evidence (RWE) \u2013 a disruptive innovation or the quiet evolution of medical evidence generation?","volume":"7","author":"Khosla S","year":"2018","unstructured":"Khosla S, White R, Medina J Real world evidence (RWE) \u2013 a disruptive innovation or the quiet evolution of medical evidence generation? F1000Research 7, 111 (2018).","journal-title":"F1000Research"},{"key":"e_1_3_6_17_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jval.2020.02.001"},{"issue":"16","key":"e_1_3_6_18_2","doi-asserted-by":"crossref","first-page":"10159","DOI":"10.3390\/ijerph191610159","article-title":"Real-world evidence-current developments and perspectives","volume":"19","author":"Schad F","year":"2022","unstructured":"Schad F, Thronicke A. Real-world evidence-current developments and perspectives. Int. J. Environ. Res. Public Health 19(16), 10159 (2022).","journal-title":"Int. J. Environ. Res. Public Health"},{"issue":"6","key":"e_1_3_6_19_2","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1016\/j.jval.2019.01.014","article-title":"Real-world evidence in healthcare decision making: global trends and case studies from Latin America","volume":"22","author":"Justo N","year":"2019","unstructured":"Justo N, Espinoza MA, Ratto B Real-world evidence in healthcare decision making: global trends and case studies from Latin America. Value Health 22(6), 739\u2013749 (2019).","journal-title":"Value Health"},{"key":"e_1_3_6_20_2","doi-asserted-by":"crossref","first-page":"1047946","DOI":"10.3389\/fphar.2022.1047946","article-title":"Drug utilization research in Peru: is real-world data available?","volume":"13","author":"Rodr\u00edguez-Tanta LY","year":"2023","unstructured":"Rodr\u00edguez-Tanta LY, Garavito Farro H, Freitas Leal L Drug utilization research in Peru: is real-world data available? Front. Pharmacol. 13, 1047946 (2023).","journal-title":"Front. Pharmacol."},{"issue":"5","key":"e_1_3_6_21_2","doi-asserted-by":"crossref","first-page":"e00661","DOI":"10.1002\/prp2.661","article-title":"Availability of secondary healthcare data for conducting pharmacoepidemiology studies in Colombia: a systematic review","volume":"8","author":"Franco JS","year":"2020","unstructured":"Franco JS, Vizcaya D. Availability of secondary healthcare data for conducting pharmacoepidemiology studies in Colombia: a systematic review. Pharmacol. Res. Perspect. 8(5), e00661 (2020).","journal-title":"Pharmacol. Res. Perspect."},{"key":"e_1_3_6_22_2","doi-asserted-by":"crossref","first-page":"b2700","DOI":"10.1136\/bmj.b2700","article-title":"The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration","volume":"339","author":"Liberati A","year":"2009","unstructured":"Liberati A, Altman DG, Tetzlaff J The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration. BMJ 339, b2700 (2009).","journal-title":"BMJ"},{"key":"e_1_3_6_23_2","doi-asserted-by":"crossref","first-page":"b2535","DOI":"10.1136\/bmj.b2535","article-title":"Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement","volume":"339","author":"Moher D","year":"2009","unstructured":"Moher D, Liberati A, Tetzlaff J, Altman DG. PRISMA Group. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. BMJ 339, b2535 (2009).","journal-title":"BMJ"},{"key":"e_1_3_6_24_2","unstructured":"The European Centres for Pharmacoepidemiology and Pharmacovigilance. Guide on methodological standards in pharmacoepidemiology (Rev. 2). (2013). Available at: http:\/\/www.encepp.eu\/standards_and_guidances"},{"issue":"4","key":"e_1_3_6_25_2","first-page":"270","article-title":"Heart rate and use of beta-blockers in mexican stable outpatients with coronary artery disease","volume":"85","author":"Alcocer-Gamba MA","year":"2015","unstructured":"Alcocer-Gamba MA, Martinez-Sanchez C, Verdejo-Paris J Heart rate and use of beta-blockers in mexican stable outpatients with coronary artery disease. Arch. Cardiol. Mex. 85(4), 270\u2013277 (2015).","journal-title":"Arch. Cardiol. Mex."},{"issue":"5","key":"e_1_3_6_26_2","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1358\/mf.2010.32.5.1465004","article-title":"Citicoline for acute ischemic stroke in mexican hospitals: a retrospective postmarketing analysis","volume":"32","author":"Leon-Jimenez C","year":"2010","unstructured":"Leon-Jimenez C, Chiquete E, Cantu C Citicoline for acute ischemic stroke in mexican hospitals: a retrospective postmarketing analysis. Methods Find. Exp. Clin. Pharmacol. 32(5), 325\u2013330 (2010).","journal-title":"Methods Find. Exp. Clin. Pharmacol."},{"issue":"3","key":"e_1_3_6_27_2","first-page":"221","article-title":"Clinical management and hospital outcomes of acute coronary syndrome patients in Mexico: The Third National Registry of Acute Coronary Syndromes (RENASICA III)","volume":"86","author":"Martinez-Sanchez C","year":"2016","unstructured":"Martinez-Sanchez C, Borrayo G, Carrillo J Clinical management and hospital outcomes of acute coronary syndrome patients in Mexico: The Third National Registry of Acute Coronary Syndromes (RENASICA III). Arch. Cardiol. Mex. 86(3), 221\u2013232 (2016).","journal-title":"Arch. Cardiol. Mex."},{"key":"e_1_3_6_28_2","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/j.ijcard.2016.08.236","article-title":"Vitamin K antagonist control in patients with atrial fibrillation in Asia compared with other regions of the world: real-world data from the GARFIELD-AF registry","volume":"223","author":"Oh S","year":"2016","unstructured":"Oh S, Goto S, Accetta G Vitamin K antagonist control in patients with atrial fibrillation in Asia compared with other regions of the world: real-world data from the GARFIELD-AF registry. Int. J. Cardiol. 223, 543\u2013547 (2016).","journal-title":"Int. J. Cardiol."},{"issue":"1","key":"e_1_3_6_29_2","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.ijcard.2012.09.096","article-title":"Gender-related differences in patients with acute heart failure: management and predictors of in-hospital mortality","volume":"168","author":"Parissis JT","year":"2013","unstructured":"Parissis JT, Mantziari L, Kaldoglou N Gender-related differences in patients with acute heart failure: management and predictors of in-hospital mortality. Int. J. Cardiol. 168(1), 185\u2013189 (2013).","journal-title":"Int. J. Cardiol."},{"issue":"1","key":"e_1_3_6_30_2","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.ijcard.2011.11.098","article-title":"Acute heart failure in patients with diabetes mellitus: clinical characteristics and predictors of in-hospital mortality","volume":"157","author":"Parissis JT","year":"2012","unstructured":"Parissis JT, Rafouli-Stergiou P, Mebazaa A Acute heart failure in patients with diabetes mellitus: clinical characteristics and predictors of in-hospital mortality. Int. J. Cardiol. 157(1), 108\u2013113 (2012).","journal-title":"Int. J. Cardiol."},{"issue":"4","key":"e_1_3_6_31_2","first-page":"411","article-title":"Impact of a community program for child malnutrition","volume":"90","author":"Perdomo CD","year":"2019","unstructured":"Perdomo CD, Rodr\u00edguez ER, Carrasco Magallanes H Impact of a community program for child malnutrition. Rev. Chil. Pediatr. 90(4), 411\u2013421 (2019).","journal-title":"Rev. Chil. Pediatr."},{"issue":"11","key":"e_1_3_6_32_2","doi-asserted-by":"crossref","first-page":"3997","DOI":"10.1210\/jc.2016-1937","article-title":"The Mexican Acromegaly Registry: clinical and biochemical characteristics at diagnosis and therapeutic outcomes","volume":"101","author":"Portocarrero-Ortiz LA","year":"2016","unstructured":"Portocarrero-Ortiz LA, Vergara-Lopez A, Vidrio-Velazquez M The Mexican Acromegaly Registry: clinical and biochemical characteristics at diagnosis and therapeutic outcomes. J. Clin. Endocrinol. Metab. 101(11), 3997\u20134004 (2016).","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"1","key":"e_1_3_6_33_2","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.jstrokecerebrovasdis.2008.09.019","article-title":"Aneurysmal subarachnoid hemorrhage in a Mexican multicenter registry of cerebrovascular disease: the RENAMEVASC study","volume":"18","author":"Ruiz-Sandoval JL","year":"2009","unstructured":"Ruiz-Sandoval JL, Cant\u00fa C, Chiquete E Aneurysmal subarachnoid hemorrhage in a Mexican multicenter registry of cerebrovascular disease: the RENAMEVASC study. J. Stroke Cerebrovasc. Dis. 18(1), 48\u201355 (2009).","journal-title":"J. Stroke Cerebrovasc. Dis."},{"issue":"5","key":"e_1_3_6_34_2","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/j.jstrokecerebrovasdis.2011.01.001","article-title":"Cerebral venous thrombosis in a Mexican multicenter registry of acute cerebrovascular disease: the RENAMEVASC study","volume":"21","author":"Ruiz-Sandoval JL","year":"2012","unstructured":"Ruiz-Sandoval JL, Chiquete E, Ba\u00f1uelos-Becerra LJ Cerebral venous thrombosis in a Mexican multicenter registry of acute cerebrovascular disease: the RENAMEVASC study. J. Stroke Cerebrovasc. Dis. 21(5), 395\u2013400 (2012).","journal-title":"J. Stroke Cerebrovasc. Dis."},{"issue":"4","key":"e_1_3_6_35_2","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1016\/j.jstrokecerebrovasdis.2014.09.008","article-title":"Implementation of a stroke registry is associated with an improvement in stroke performance measures in a tertiary hospital in Mexico","volume":"24","author":"Herrera AL","year":"2015","unstructured":"Herrera AL, G\u00f3ngora-Rivera F, Muruet W Implementation of a stroke registry is associated with an improvement in stroke performance measures in a tertiary hospital in Mexico. J. Stroke Cerebrovasc. Dis. 24(4), 725\u2013730 (2015).","journal-title":"J. Stroke Cerebrovasc. Dis."},{"issue":"5","key":"e_1_3_6_36_2","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1002\/clc.23176","article-title":"Stroke prevention in patients from Latin American countries with non-valvular atrial fibrillation: insights from the GARFIELD-AF registry","volume":"42","author":"Jerjes-Sanchez C","year":"2019","unstructured":"Jerjes-Sanchez C, Corbalan R, Barretto ACP Stroke prevention in patients from Latin American countries with non-valvular atrial fibrillation: insights from the GARFIELD-AF registry. Clin. Cardiol. 42(5), 553\u2013560 (2019).","journal-title":"Clin. Cardiol."},{"issue":"3","key":"e_1_3_6_37_2","first-page":"154","article-title":"In-hospital outcome in patients with ST elevation myocardial infarction and right bundle branch block. A sub-study from RENASICA II, a national multicenter registry","volume":"80","author":"Ju\u00e1rez-Herrera U","year":"2010","unstructured":"Ju\u00e1rez-Herrera U, Jerjes S\u00e1nchez C, Gonz\u00e1lez-Pacheco H In-hospital outcome in patients with ST elevation myocardial infarction and right bundle branch block. A sub-study from RENASICA II, a national multicenter registry. Arch. Cardiol. Mex. 80(3), 154\u2013158 (2010).","journal-title":"Arch. Cardiol. Mex."},{"issue":"7","key":"e_1_3_6_38_2","doi-asserted-by":"crossref","first-page":"NP19","DOI":"10.1177\/1747493018790130","article-title":"Onset-to-alarm time in patients with acute stroke: results from a Mexican population","volume":"13","author":"Gonzalez-Aquines A","year":"2018","unstructured":"Gonzalez-Aquines A, Cordero-Perez AC, Ramirez-Martinez LA Onset-to-alarm time in patients with acute stroke: results from a Mexican population. Int. J. Stroke 13(7), NP19\u2013NP21 (2018).","journal-title":"Int. J. Stroke"},{"issue":"3","key":"e_1_3_6_39_2","first-page":"232","article-title":"RENASICA II: a Mexican acute myocardial infarction registry that highlights the importance of regional registries","volume":"2014","author":"Suwaidi JA","year":"2014","unstructured":"Suwaidi JA. RENASICA II: a Mexican acute myocardial infarction registry that highlights the importance of regional registries. Glob. Cardiol. Sci. Pract. 2014(3), 232\u2013234 (2014).","journal-title":"Glob. Cardiol. Sci. Pract."},{"issue":"1","key":"e_1_3_6_40_2","first-page":"14","article-title":"Clinical characteristics, process of care and outcomes among Mexican, Hispanic and non-Hispanic white patients presenting with non-ST elevation acute coronary syndromes: data from RENASICA and CRUSADE registries","volume":"82","author":"S\u00e1nchez-Diaz CJ","year":"2012","unstructured":"S\u00e1nchez-Diaz CJ, Garc\u00eda-Badillo E, S\u00e1nchez-Ram\u00edrez CJ Clinical characteristics, process of care and outcomes among Mexican, Hispanic and non-Hispanic white patients presenting with non-ST elevation acute coronary syndromes: data from RENASICA and CRUSADE registries. Arch. Cardiol. Mex. 82(1), 14\u201321 (2012).","journal-title":"Arch. Cardiol. Mex."},{"issue":"2","key":"e_1_3_6_41_2","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1007\/s00408-016-9842-y","article-title":"Chronic thromboembolic pulmonary hypertension: experience from a single center in Mexico","volume":"194","author":"Al-Naamani N","year":"2016","unstructured":"Al-Naamani N, Espitia HG, Velazquez-Moreno H Chronic thromboembolic pulmonary hypertension: experience from a single center in Mexico. Lung 194(2), 315\u2013323 (2016).","journal-title":"Lung"},{"key":"e_1_3_6_42_2","first-page":"117","article-title":"Gender differences and management of stroke risk of nonvalvular atrial fibrillation in an upper middle-income country: insights from the CARMEN-AF registry","volume":"22","author":"Antonio Gonzalez-Hermosillo J","year":"2019","unstructured":"Antonio Gonzalez-Hermosillo J, Banos-Gonzalez MA, Guevara-Valdivia ME Gender differences and management of stroke risk of nonvalvular atrial fibrillation in an upper middle-income country: insights from the CARMEN-AF registry. Int. J. Cardiol. Heart Vasc. 22, 117\u2013122 (2019).","journal-title":"Int. J. Cardiol. Heart Vasc."},{"issue":"4","key":"e_1_3_6_43_2","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1111\/ijs.12239","article-title":"Differences in lipid profiles in two Hispanic ischemic stroke populations","volume":"9","author":"Arauz A","year":"2014","unstructured":"Arauz A, Romano JG, Ruiz-Franco A Differences in lipid profiles in two Hispanic ischemic stroke populations. Int. J. Stroke 9(4), 394\u2013399 (2014).","journal-title":"Int. J. Stroke"},{"issue":"1","key":"e_1_3_6_44_2","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1007\/s00392-017-1161-7","article-title":"Association of mineralocorticoid receptor antagonist use and in-hospital outcomes in patients with acute heart failure","volume":"107","author":"Bistola V","year":"2018","unstructured":"Bistola V, Simitsis P, Farmakis D Association of mineralocorticoid receptor antagonist use and in-hospital outcomes in patients with acute heart failure. Clin. Res. Cardiol. 107(1), 76\u201386 (2018).","journal-title":"Clin. Res. Cardiol."},{"issue":"8","key":"e_1_3_6_45_2","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/j.arcmed.2019.01.005","article-title":"STEMI and NSTEMI: real-world study in Mexico (RENASCA)","volume":"49","author":"Borrayo-S\u00e1nchez G","year":"2018","unstructured":"Borrayo-S\u00e1nchez G, Rosas-Peralta M, Ram\u00edrez-Arias E STEMI and NSTEMI: real-world study in Mexico (RENASCA). Arch. Med. Res. 49(8), 609\u2013619 (2018).","journal-title":"Arch. Med. Res."},{"issue":"4","key":"e_1_3_6_46_2","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1161\/CIRCEP.112.970749","article-title":"Distribution and risk profile of paroxysmal, persistent, and permanent atrial fibrillation in routine clinical practice: insight from the real-life global survey evaluating patients with atrial fibrillation international registry","volume":"5","author":"Chiang CE","year":"2012","unstructured":"Chiang CE, Naditch-Br\u00fbl\u00e9 L, Murin J Distribution and risk profile of paroxysmal, persistent, and permanent atrial fibrillation in routine clinical practice: insight from the real-life global survey evaluating patients with atrial fibrillation international registry. Circ. Arrhythm. Electrophysiol. 5(4), 632\u2013639 (2012).","journal-title":"Circ. Arrhythm. Electrophysiol."},{"issue":"2","key":"e_1_3_6_47_2","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1159\/000346603","article-title":"Serum uric acid and outcome after acute ischemic stroke: PREMIER study","volume":"35","author":"Chiquete E","year":"2013","unstructured":"Chiquete E, Ruiz-Sandoval JL, Murillo-Bonilla LM Serum uric acid and outcome after acute ischemic stroke: PREMIER study. Cerebrovasc. Dis. 35(2), 168\u2013174 (2013).","journal-title":"Cerebrovasc. Dis."},{"issue":"19","key":"e_1_3_6_48_2","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.1016\/j.ehj.2003.07.002","article-title":"Intra-aortic balloon counterpulsation in US and non-US centres: results of the Benchmark Registry","volume":"24","author":"Cohen M","year":"2003","unstructured":"Cohen M, Urban P, Christenson JT Intra-aortic balloon counterpulsation in US and non-US centres: results of the Benchmark Registry. Eur. Heart J. 24(19), 1763\u20131770 (2003).","journal-title":"Eur. Heart J."},{"issue":"1","key":"e_1_3_6_49_2","first-page":"334","article-title":"In-hospital management and outcome of Acute Coronary Syndromes (ACS) in developing countries: results of the ACCESS registry","volume":"30","author":"Montalescot G","year":"2009","unstructured":"Montalescot G, Sobhy M, Alam S In-hospital management and outcome of Acute Coronary Syndromes (ACS) in developing countries: results of the ACCESS registry. Eur. Heart J. 30(Suppl. 1), 334\u2013335 (2009).","journal-title":"Eur. Heart J."},{"issue":"1","key":"e_1_3_6_50_2","first-page":"838","article-title":"Acute heart failure with preserved left ventricular ejection fraction in the ALARM-HF registry: predictors of in-hospital mortality","volume":"30","author":"Parissis JT","year":"2009","unstructured":"Parissis JT, Farmakis D, Ikonomidis I Acute heart failure with preserved left ventricular ejection fraction in the ALARM-HF registry: predictors of in-hospital mortality. Eur. Heart J. 30(Suppl. 1), 838\u2013839 (2009).","journal-title":"Eur. Heart J."},{"issue":"1","key":"e_1_3_6_51_2","first-page":"326","article-title":"Body mass index and disease-modifying therapy in acute heart failure patients","volume":"34","author":"Parissis JT","year":"2013","unstructured":"Parissis JT, Fountoulaki K, Farmakis D Body mass index and disease-modifying therapy in acute heart failure patients. Eur. Heart J. 34(Suppl. 1), 326 (2013).","journal-title":"Eur. Heart J."},{"issue":"12","key":"e_1_3_6_52_2","first-page":"A377","article-title":"Venous thromboembolic disease and thromboprophylaxis: experience in a medical-surgical ICU in Mexico","volume":"37","author":"Rada FP","year":"2009","unstructured":"Rada FP, Suarez VP, Fernandez-Rangel E Venous thromboembolic disease and thromboprophylaxis: experience in a medical-surgical ICU in Mexico. Crit. Care Med. 37(Suppl. 12), A377 (2009).","journal-title":"Crit. Care Med."},{"issue":"1","key":"e_1_3_6_53_2","first-page":"60","article-title":"[Analysis of the inclusion of police personnel on the out of hospital cardiac arrest emergency response]","volume":"54","author":"Aguilera-Campos A","year":"2012","unstructured":"Aguilera-Campos A, Asensio-Lafuente E, Fraga-Sastr\u00edas JM. [Analysis of the inclusion of police personnel on the out of hospital cardiac arrest emergency response]. Salud Publica Mex. 54(1), 60\u201367 (2012).","journal-title":"Salud Publica Mex."},{"issue":"2","key":"e_1_3_6_54_2","first-page":"168","article-title":"Global cardiovascular risk stratification: comparison of the Framingham method with the SCORE method in the Mexican population","volume":"79","author":"Alcocer LA","year":"2011","unstructured":"Alcocer LA, Lozada O, Fangh\u00e4nel G Global cardiovascular risk stratification: comparison of the Framingham method with the SCORE method in the Mexican population. Cir. Cir. 79(2), 168\u2013174 (2011).","journal-title":"Cir. Cir."},{"issue":"6","key":"e_1_3_6_55_2","first-page":"530","article-title":"Short-term prognosis of transient ischemic attacks. Mexican multicenter stroke registry. [Spanish]","volume":"58","author":"Arauz-Gongora A","year":"2006","unstructured":"Arauz-Gongora A, Cantu C, Ruiz-Sandoval JL Short-term prognosis of transient ischemic attacks. Mexican multicenter stroke registry. [Spanish]. Rev. Invest. Clin. 58(6), 530\u2013539 (2006).","journal-title":"Rev. Invest. Clin."},{"issue":"5","key":"e_1_3_6_56_2","first-page":"224","article-title":"Risk factors, causes, and outcome in stroke types in Mexico. The RENAMEVASC Study","volume":"12","author":"Cantu-Brito C","year":"2011","unstructured":"Cantu-Brito C, Ruiz-Sandoval JL, Chiquete E Risk factors, causes, and outcome in stroke types in Mexico. The RENAMEVASC Study. Rev. Mex. Neuroci. 12(5), 224\u2013234 (2011).","journal-title":"Rev. Mex. Neuroci."},{"issue":"1","key":"e_1_3_6_57_2","first-page":"S58","article-title":"[Cardiovascular risk in children from 6 to 15 years with exogenous obesity]","volume":"52","author":"Escudero-Lourdes GV","year":"2014","unstructured":"Escudero-Lourdes GV, Morales-Romero LV, Valverde-Oca\u00f1a C [Cardiovascular risk in children from 6 to 15 years with exogenous obesity]. Rev. Med. Inst. Mex. Seguro Soc. 52(Suppl. 1), S58\u2013S63 (2014).","journal-title":"Rev. Med. Inst. Mex. Seguro Soc."},{"issue":"1","key":"e_1_3_6_58_2","first-page":"5","article-title":"[Design of an atrial fibrillation and embolic risk registry in Mexico: CARMEN-AF]","volume":"87","author":"Gonz\u00e1lez-Hermosillo JA","year":"2017","unstructured":"Gonz\u00e1lez-Hermosillo JA, M\u00e1rquez MF, Ocampo-Pe\u00f1a S. [Design of an atrial fibrillation and embolic risk registry in Mexico: CARMEN-AF]. Arch. Cardiol. Mex. 87(1), 5\u201312 (2017).","journal-title":"Arch. Cardiol. Mex."},{"issue":"4","key":"e_1_3_6_59_2","first-page":"382","article-title":"[Registry of myocardial infarction in a tertiary hospital of the Instituto Mexicano del Seguro Social]","volume":"52","author":"Gonz\u00e1lez-Pliego JA","year":"2014","unstructured":"Gonz\u00e1lez-Pliego JA, Gudi\u00f1o-Amezcua DA, Celis A [Registry of myocardial infarction in a tertiary hospital of the Instituto Mexicano del Seguro Social]. Rev. Med. Inst. Mex. Seguro Soc. 52(4), 382\u2013387 (2014).","journal-title":"Rev. Med. Inst. Mex. Seguro Soc."},{"issue":"1","key":"e_1_3_6_60_2","first-page":"13","article-title":"[Design of a multicenter registry to evaluate rhythm versus rate control in atrial fibrillation: Atrial Fibrillation Mexican Registry (ReMeFA)]","volume":"81","author":"Iturralde-Torres P","year":"2011","unstructured":"Iturralde-Torres P, Lara-Vaca S, Cordero-Cabra A [Design of a multicenter registry to evaluate rhythm versus rate control in atrial fibrillation: Atrial Fibrillation Mexican Registry (ReMeFA)]. Arch. Cardiol. Mex. 81(1), 13\u201317 (2011).","journal-title":"Arch. Cardiol. Mex."},{"issue":"2","key":"e_1_3_6_61_2","first-page":"S45","article-title":"[National registry of acute ischemic coronary syndromes (RENASICA). Mexican Cardiology Society. The RENASICA Cooperative Group]","volume":"72","author":"Lupi Herrera E","year":"2022","unstructured":"Lupi Herrera E. [National registry of acute ischemic coronary syndromes (RENASICA). Mexican Cardiology Society. The RENASICA Cooperative Group]. Arch. Cardiol. Mex. 72(Suppl. 2), S45\u2013S64 (2022).","journal-title":"Arch. Cardiol. Mex."},{"issue":"2","key":"e_1_3_6_62_2","first-page":"86","article-title":"[Analysis of clinical, echocardiographic, microbiological and cytopathological characteristics of pericardial effusions in a tertiary hospital care]","volume":"84","author":"Santa Cruz-Ruiz JM","year":"2014","unstructured":"Santa Cruz-Ruiz JM, Sahag\u00fan-S\u00e1nchez G, Gonz\u00e1lez-Cabello D [Analysis of clinical, echocardiographic, microbiological and cytopathological characteristics of pericardial effusions in a tertiary hospital care]. Arch. Cardiol. Mex. 84(2), 86\u201391 (2014).","journal-title":"Arch. Cardiol. Mex."},{"issue":"1","key":"e_1_3_6_63_2","doi-asserted-by":"crossref","first-page":"S6","DOI":"10.21149\/spm.v57s1.7584","article-title":"Contribution of socioeconomic factors and health care access to the awareness and treatment of diabetes and hypertension among older Mexican adults","volume":"57","author":"Beltr\u00e1n-S\u00e1nchez H","year":"2015","unstructured":"Beltr\u00e1n-S\u00e1nchez H, Drumond-Andrade FC, Riosmena F. Contribution of socioeconomic factors and health care access to the awareness and treatment of diabetes and hypertension among older Mexican adults. Salud Publica Mex. 57 (Suppl. 1), S6\u2013S14 (2015).","journal-title":"Salud Publica Mex."},{"issue":"4","key":"e_1_3_6_64_2","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1093\/intqhc\/mzy012","article-title":"Loss of job-related right to healthcare is associated with reduced quality and clinical outcomes of diabetic patients in Mexico","volume":"30","author":"Doubova SV","year":"2018","unstructured":"Doubova SV, Borja-Aburto VH, Guerra YGG Loss of job-related right to healthcare is associated with reduced quality and clinical outcomes of diabetic patients in Mexico. Int. J. Qual. Health Care 30(4), 283\u2013290 (2018).","journal-title":"Int. J. Qual. Health Care"},{"issue":"3","key":"e_1_3_6_65_2","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.annepidem.2015.12.006","article-title":"Prediabetes, undiagnosed diabetes, and diabetes among Mexican adults: findings from the Mexican Health and Aging Study","volume":"26","author":"Kumar A","year":"2016","unstructured":"Kumar A, Wong R, Ottenbacher KJ Prediabetes, undiagnosed diabetes, and diabetes among Mexican adults: findings from the Mexican Health and Aging Study. Ann. Epidemiol. 26(3), 163\u2013170 (2016).","journal-title":"Ann. Epidemiol."},{"issue":"1","key":"e_1_3_6_66_2","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1093\/ije\/dyt215","article-title":"Hypertension among older adults in low and middle-income countries: prevalence, awareness and control","volume":"43","author":"Lloyd-Sherlock P","year":"2014","unstructured":"Lloyd-Sherlock P, Beard J, Minicuci N Hypertension among older adults in low and middle-income countries: prevalence, awareness and control. Int. J. Epidemiol. 43(1), 116\u2013128 (2014).","journal-title":"Int. J. Epidemiol."},{"issue":"9","key":"e_1_3_6_67_2","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1080\/10245332.2018.1461290","article-title":"Iron deficiency anemia referral to the hematologist. Real-world data from Mexico: the need for targeted teaching in primary care","volume":"23","author":"Lopez-Garcia YK","year":"2018","unstructured":"Lopez-Garcia YK, Colunga-Pedraza PR, Tarin-Arzaga L Iron deficiency anemia referral to the hematologist. Real-world data from Mexico: the need for targeted teaching in primary care. Hematology 23(9), 658\u2013663 (2018).","journal-title":"Hematology"},{"issue":"1","key":"e_1_3_6_68_2","doi-asserted-by":"crossref","first-page":"101","DOI":"10.3390\/nu10010101","article-title":"Modifications in the consumption of energy, sugar, and saturated fat among the Mexican adult population: simulation of the effect when replacing processed foods that comply with a front of package labeling system","volume":"10","author":"Mendoza R","year":"2018","unstructured":"Mendoza R, Tolentino-Mayo L, Hern\u00e1ndez-Barrera L Modifications in the consumption of energy, sugar, and saturated fat among the Mexican adult population: simulation of the effect when replacing processed foods that comply with a front of package labeling system. Nutrients 10(1), 101 (2018).","journal-title":"Nutrients"},{"issue":"2","key":"e_1_3_6_69_2","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1007\/s11255-008-9417-9","article-title":"Prostatic profile, premature ejaculation, erectile function and andropause in an at-risk Mexican population","volume":"41","author":"Jaspersen-Gastelum J","year":"2009","unstructured":"Jaspersen-Gastelum J, Rodr\u00edguez JA, Espinosa de los Monteros FJ Prostatic profile, premature ejaculation, erectile function and andropause in an at-risk Mexican population. Int. Urol. Nephrol. 41(2), 303\u2013312 (2009).","journal-title":"Int. Urol. Nephrol."},{"issue":"2","key":"e_1_3_6_70_2","doi-asserted-by":"crossref","first-page":"425","DOI":"10.2337\/diacare.28.2.425","article-title":"Differences in access to health care services between insured and uninsured adults with diabetes in Mexico","volume":"28","author":"Pagan JA","year":"2005","unstructured":"Pagan JA, Puig A. Differences in access to health care services between insured and uninsured adults with diabetes in Mexico. Diabetes Care 28(2), 425\u2013426 (2005).","journal-title":"Diabetes Care"},{"key":"e_1_3_6_71_2","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.vhri.2019.02.007","article-title":"Resource utilization and costs associated with percutaneous coronary intervention when treating patients with acute coronary syndrome in the Mexican National Institute of Cardiology \u201cIgnacio Chavez\u201d","volume":"20","author":"Jones K","year":"2019","unstructured":"Jones K, Ramirez J, Papadimitropoulos M Resource utilization and costs associated with percutaneous coronary intervention when treating patients with acute coronary syndrome in the Mexican National Institute of Cardiology \u201cIgnacio Chavez\u201d. Value Health Reg. Issues 20, 136\u2013141 (2019).","journal-title":"Value Health Reg. Issues"},{"issue":"13","key":"e_1_3_6_72_2","doi-asserted-by":"crossref","first-page":"29","DOI":"10.5414\/CNP86S105","article-title":"Burden of end-stage renal disease (ESRD) in Latin America","volume":"86","author":"Rosa-Diez G","year":"2016","unstructured":"Rosa-Diez G, Gonzalez-Bedat M, Ferreiro A Burden of end-stage renal disease (ESRD) in Latin America. Clin. Nephrol. 86(13), 29\u201333 (2016).","journal-title":"Clin. Nephrol."},{"issue":"2","key":"e_1_3_6_73_2","doi-asserted-by":"crossref","first-page":"97","DOI":"10.3390\/nu9020097","article-title":"Association between obesity and serum 25(OH)D concentrations in older Mexican adults","volume":"9","author":"Rontoyanni VG","year":"2017","unstructured":"Rontoyanni VG, Avila JC, Kaul S Association between obesity and serum 25(OH)D concentrations in older Mexican adults. Nutrients 9(2), 97 (2017).","journal-title":"Nutrients"},{"issue":"10","key":"e_1_3_6_74_2","doi-asserted-by":"crossref","first-page":"e017330","DOI":"10.1136\/bmjopen-2017-017330","article-title":"Projecting diabetes prevalence among Mexicans aged 50 years and older: the Future Elderly Model-Mexico (FEM-Mexico)","volume":"7","author":"Gonzalez-Gonzalez C","year":"2017","unstructured":"Gonzalez-Gonzalez C, Tysinger B, Goldman DP Projecting diabetes prevalence among Mexicans aged 50 years and older: the Future Elderly Model-Mexico (FEM-Mexico). BMJ Open 7(10), e017330 (2017).","journal-title":"BMJ Open"},{"issue":"1","key":"e_1_3_6_75_2","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1186\/s12913-018-3283-7","article-title":"Loss of job-related right to healthcare associated with employment turnover: challenges for the Mexican health system","volume":"18","author":"Guerra G","year":"2018","unstructured":"Guerra G, Gutierrez-Calderon E, Salgado de Snyder N Loss of job-related right to healthcare associated with employment turnover: challenges for the Mexican health system. BMC Health Serv. Res. 18(1), 457 (2018).","journal-title":"BMC Health Serv. Res."},{"issue":"6","key":"e_1_3_6_76_2","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1159\/000098142","article-title":"Distribution of anemia associated with micronutrient deficiencies other than iron in a probabilistic sample of Mexican children","volume":"50","author":"Villalpando S","year":"2006","unstructured":"Villalpando S, P\u00e9rez-Exp\u00f3sito AB, Shamah-Levy T Distribution of anemia associated with micronutrient deficiencies other than iron in a probabilistic sample of Mexican children. Ann. Nutr. Metab. 50(6), 506\u2013511 (2006).","journal-title":"Ann. Nutr. Metab."},{"key":"e_1_3_6_77_2","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.ehb.2015.04.002","article-title":"The impact of diabetes on employment in Mexico","volume":"18","author":"Seuring T","year":"2015","unstructured":"Seuring T, Goryakin Y, Suhrcke M. The impact of diabetes on employment in Mexico. Econ. Hum. Biol. 18, 85\u2013100 (2015).","journal-title":"Econ. Hum. Biol."},{"issue":"7","key":"e_1_3_6_78_2","doi-asserted-by":"crossref","first-page":"512","DOI":"10.2471\/BLT.08.053256","article-title":"Diabetes treatment and control: the effect of public health insurance for the poor in Mexico","volume":"87","author":"Sosa-Rubi SG","year":"2009","unstructured":"Sosa-Rubi SG, Galarraga O, Lopez-Ridaura R. Diabetes treatment and control: the effect of public health insurance for the poor in Mexico. Bull. World Health Organ. 87(7), 512\u2013519 (2009).","journal-title":"Bull. World Health Organ."},{"issue":"11","key":"e_1_3_6_79_2","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1016\/j.socscimed.2011.09.006","article-title":"The influence of indigenous status and community indigenous composition on obesity and diabetes among Mexican adults","volume":"73","author":"Stoddard P","year":"2011","unstructured":"Stoddard P, Handley MA, Vargas Bustamante A The influence of indigenous status and community indigenous composition on obesity and diabetes among Mexican adults. Soc. Sci. Med. 73(11), 1635\u20131643 (2011).","journal-title":"Soc. Sci. Med."},{"issue":"1","key":"e_1_3_6_80_2","first-page":"S110","article-title":"[Improvement of child survival in Mexico: the diagonal approach]","volume":"49","author":"Sep\u00falveda J","year":"2007","unstructured":"Sep\u00falveda J, Bustreo F, Tapia R [Improvement of child survival in Mexico: the diagonal approach]. Salud Publica Mex. 49(Suppl. 1), S110\u2013S125 (2007).","journal-title":"Salud Publica Mex."},{"issue":"2","key":"e_1_3_6_81_2","first-page":"174","article-title":"Pre-hospital delay of patients with ST-elevation myocardial infarction in Mexico City","volume":"89","author":"Araiza-Garaygordobil D","year":"2019","unstructured":"Araiza-Garaygordobil D, Gonzalez-Pacheco H, Sierra-Fernandez C Pre-hospital delay of patients with ST-elevation myocardial infarction in Mexico City. Arch. Cardiol. Mex. 89(2), 174\u2013176 (2019).","journal-title":"Arch. Cardiol. Mex."},{"issue":"1","key":"e_1_3_6_82_2","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.arcmed.2018.04.005","article-title":"10 years analysis of diabetes-related major lower extremity amputations in Mexico","volume":"49","author":"Ascencio-Montiel IJ","year":"2018","unstructured":"Ascencio-Montiel IJ. 10 years analysis of diabetes-related major lower extremity amputations in Mexico. Arch. Med. Res. 49(1), 58\u201364 (2018).","journal-title":"Arch. Med. Res."},{"issue":"5","key":"e_1_3_6_83_2","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/S0188-4409(03)00075-4","article-title":"Geography of diabetes mellitus mortality in Mexico: an epidemiologic transition analysis","volume":"34","author":"Barquera S","year":"2003","unstructured":"Barquera S, Tovar-Guzm\u00e1n V, Campos-Nonato I Geography of diabetes mellitus mortality in Mexico: an epidemiologic transition analysis. Arch. Med. Res. 34(5), 407\u2013414 (2003).","journal-title":"Arch. Med. Res."},{"issue":"3","key":"e_1_3_6_84_2","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1111\/j.1728-4465.2006.00098.x","article-title":"Over-the-Counter access, changing who guidelines, and contraindicated oral contraceptive use in Mexico","volume":"37","author":"Yeatman SE","year":"2006","unstructured":"Yeatman SE, Potter JE, Grossman DA. Over-the-Counter access, changing who guidelines, and contraindicated oral contraceptive use in Mexico. Stud. Fam. Plann. 37(3), 197\u2013204 (2006).","journal-title":"Stud. Fam. Plann."},{"issue":"1","key":"e_1_3_6_85_2","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1186\/s12911-019-0950-5","article-title":"Application of machine learning methodology to assess the performance of DIABETIMSS program for patients with Type 2 diabetes in family medicine clinics in Mexico","volume":"19","author":"You Y","year":"2019","unstructured":"You Y, Doubova SV, Pinto-Masis D Application of machine learning methodology to assess the performance of DIABETIMSS program for patients with Type 2 diabetes in family medicine clinics in Mexico. BMC Med. Inform. Decis. Mak. 19(1), 221 (2019).","journal-title":"BMC Med. Inform. Decis. Mak."},{"issue":"4","key":"e_1_3_6_86_2","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1016\/j.jstrokecerebrovasdis.2016.09.042","article-title":"Temporal trends in mortality from ischemic and hemorrhagic stroke in Mexico, 1980\u20132012","volume":"26","author":"Cruz C","year":"2017","unstructured":"Cruz C, Campuzano-Rinc\u00f3n JC, Calleja-Castillo JM Temporal trends in mortality from ischemic and hemorrhagic stroke in Mexico, 1980\u20132012. J. Stroke Cerebrovasc. Dis. 26(4), 725\u2013732 (2017).","journal-title":"J. Stroke Cerebrovasc. Dis."},{"issue":"1","key":"e_1_3_6_87_2","doi-asserted-by":"crossref","first-page":"46","DOI":"10.3109\/03014460.2013.824024","article-title":"Food intake and nutrition in children 1\u20134 years of age in Yucatan, Mexico","volume":"41","author":"Cuanalo de la Cerda HE","year":"2014","unstructured":"Cuanalo de la Cerda HE, Ochoa Estrada E, Tuz Poot FR Food intake and nutrition in children 1\u20134 years of age in Yucatan, Mexico. Ann. Hum. Biol. 41(1), 46\u201352 (2014).","journal-title":"Ann. Hum. Biol."},{"key":"e_1_3_6_88_2","doi-asserted-by":"crossref","first-page":"S46","DOI":"10.1111\/j.1523-1755.2005.09708.x","article-title":"The Latin American Dialysis and Renal Transplantation Registry Annual Report 2002","volume":"97","author":"Cusumano AM","year":"2005","unstructured":"Cusumano AM, Di Gioia C, Hermida O The Latin American Dialysis and Renal Transplantation Registry Annual Report 2002. Kidney Int. Suppl. 97, S46\u2013S52 (2005).","journal-title":"Kidney Int. Suppl."},{"issue":"8","key":"e_1_3_6_89_2","doi-asserted-by":"crossref","first-page":"1714","DOI":"10.1097\/HJH.0b013e3283613090","article-title":"Use of electronic health records to evaluate the quality of care for hypertensive patients in Mexican family medicine clinics","volume":"31","author":"Doubova SV","year":"2013","unstructured":"Doubova SV, Lamadrid-Figueroa H, P\u00e9rez-Cuevas R. Use of electronic health records to evaluate the quality of care for hypertensive patients in Mexican family medicine clinics. J. Hypertens. 31(8), 1714\u20131723 (2013).","journal-title":"J. Hypertens."},{"issue":"3","key":"e_1_3_6_90_2","first-page":"C53","article-title":"Evolution of GFR outcomes during the first year of transplant according to the kidney donor risk index transplantation in Mexico. The experience of a single center [abstract]","volume":"15","author":"Aguilar-Frasco J","year":"2015","unstructured":"Aguilar-Frasco J, Arreola-Guerra J, Palau L Evolution of GFR outcomes during the first year of transplant according to the kidney donor risk index transplantation in Mexico. The experience of a single center [abstract]. Am. J. Transplant. 15(Suppl. 3), C53 (2015).","journal-title":"Am. J. Transplant."},{"issue":"2","key":"e_1_3_6_91_2","first-page":"880","article-title":"Eating habits of breakfast and lunch in Mexican children","volume":"71","author":"Chavez Palencia C","year":"2017","unstructured":"Chavez Palencia C, Arellano Gomez L. Eating habits of breakfast and lunch in Mexican children. Ann. Nutr. Metab. 71(Suppl. 2), 880\u2013881 (2017).","journal-title":"Ann. Nutr. Metab."},{"issue":"2","key":"e_1_3_6_92_2","first-page":"S292","article-title":"Cognitive function changes in patients with diabetes mellitus in Mexican population in ENASEM","volume":"66","author":"Galvan V","year":"2018","unstructured":"Galvan V, Jimenez GA, Moctezuma R Cognitive function changes in patients with diabetes mellitus in Mexican population in ENASEM. J. Am. Geriatr. Soc. 66(Suppl. 2), S292 (2018).","journal-title":"J. Am. Geriatr. Soc."},{"issue":"1","key":"e_1_3_6_93_2","doi-asserted-by":"crossref","first-page":"e379","DOI":"10.1016\/j.jns.2015.08.1349","article-title":"Retrospective registry of cerebrovascular disease in a private third level referral academic hospital (Fundacion Clinica Medica Sur) in Mexico City","volume":"357","author":"Godinez Olivas HF","year":"2015","unstructured":"Godinez Olivas HF, Nader Kawachi JA, Cano Nigenda CV Retrospective registry of cerebrovascular disease in a private third level referral academic hospital (Fundacion Clinica Medica Sur) in Mexico City. J. Neurol. Sci. 357(Suppl. 1), e379 (2015).","journal-title":"J. Neurol. Sci."},{"issue":"2","key":"e_1_3_6_94_2","first-page":"S284","article-title":"Deficit-direct effect of insulin on cognitive impairment treatment","volume":"66","author":"Jimenez GA","year":"2018","unstructured":"Jimenez GA, Barragan A. Deficit-direct effect of insulin on cognitive impairment treatment. J. Am. Geriatr. Soc. 66 (Suppl. 2), S284 (2018).","journal-title":"J. Am. Geriatr. Soc."},{"issue":"3","key":"e_1_3_6_95_2","doi-asserted-by":"crossref","first-page":"A129","DOI":"10.1016\/j.jval.2014.03.752","article-title":"Estimating the cost of treating hypoglycemc events in the Mexican public health care system","volume":"17","author":"Jimenez P","year":"2014","unstructured":"Jimenez P, Pastor V, Luna G. Estimating the cost of treating hypoglycemc events in the Mexican public health care system. Value Health 17(3), A129\u2013A130 (2014).","journal-title":"Value Health"},{"issue":"2","key":"e_1_3_6_96_2","first-page":"18","article-title":"Prevalence of cardiovascular risk factors in persons living with HIV at high activity antiretroviral therapy in Mexico City","volume":"18","author":"Lara MV","year":"2015","unstructured":"Lara MV, Rodriguez CM. Prevalence of cardiovascular risk factors in persons living with HIV at high activity antiretroviral therapy in Mexico City. J. Int. AIDS Soc. 18(2 Suppl. 3), 18\u201319 (2015).","journal-title":"J. Int. AIDS Soc."},{"issue":"2","key":"e_1_3_6_97_2","first-page":"12","article-title":"Cardiovascular risk assessment In HIV patients of an outpatient HIV clinic in Mexico City","volume":"16","author":"Magis-Rodriguez C","year":"2013","unstructured":"Magis-Rodriguez C, Casillas J, Alvarez-Wyssmann V Cardiovascular risk assessment In HIV patients of an outpatient HIV clinic in Mexico City. J. Int. AIDS Soc. 16(2S1), 12 (2013).","journal-title":"J. Int. AIDS Soc."},{"issue":"7","key":"e_1_3_6_98_2","doi-asserted-by":"crossref","first-page":"A537","DOI":"10.1016\/j.jval.2011.08.1526","article-title":"Cost-utility of sacral neuromodulation versus augmentation cystoplasty for treatment of refractory urge incontinence in Mexico","volume":"14","author":"Oliva-Oropeza P","year":"2011","unstructured":"Oliva-Oropeza P, Quiroz Angulo ME, Marco Antonio AC. Cost-utility of sacral neuromodulation versus augmentation cystoplasty for treatment of refractory urge incontinence in Mexico. Value Health 14(7), A537 (2011).","journal-title":"Value Health"},{"issue":"7","key":"e_1_3_6_99_2","doi-asserted-by":"crossref","first-page":"A497","DOI":"10.1016\/j.jval.2012.08.1666","article-title":"Economic impact of analogue insulin on health expenditure at the Mexican Institute of Social Security in 2012. An expenditure reduction proposal","volume":"15","author":"Panopoulou P","year":"2012","unstructured":"Panopoulou P, Garcia-Contreras F, Paladio-Hernandez JA Economic impact of analogue insulin on health expenditure at the Mexican Institute of Social Security in 2012. An expenditure reduction proposal. Value Health 15(7), A497 (2012).","journal-title":"Value Health"},{"issue":"7","key":"e_1_3_6_100_2","doi-asserted-by":"crossref","first-page":"A689","DOI":"10.1016\/j.jval.2013.08.2054","article-title":"Cost-effectiveness of paricalcitol versus parathyroidectomy for secondary hyperparathyroidism to chronic kidney disease in Mexico","volume":"16","author":"Sanchez-Casillas JL","year":"2013","unstructured":"Sanchez-Casillas JL, Ramirez-Lopez-De NMG. Cost-effectiveness of paricalcitol versus parathyroidectomy for secondary hyperparathyroidism to chronic kidney disease in Mexico. Value Health 16(7), A689 (2013).","journal-title":"Value Health"},{"key":"e_1_3_6_101_2","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1097\/00007890-201007272-01816","article-title":"Fert results (results of the collaborative retrospective study in renal transplantation in Mexico","volume":"90","author":"Noyola-Villalobos HF","year":"2010","unstructured":"Noyola-Villalobos HF, Alberu-Gomez J, Gracida C Fert results (results of the collaborative retrospective study in renal transplantation in Mexico. Transplantation 90, 926 (2010).","journal-title":"Transplantation"},{"issue":"1","key":"e_1_3_6_102_2","first-page":"1831","article-title":"Synergy of artificial intelligence and single lead EKG to detect and localize STEMI","volume":"40","author":"Vieira D","year":"2019","unstructured":"Vieira D, Mehta S, Fernandez F Synergy of artificial intelligence and single lead EKG to detect and localize STEMI. Eur. Heart J. 40(Suppl. 1), 1831 (2019).","journal-title":"Eur. Heart J."},{"issue":"3","key":"e_1_3_6_103_2","doi-asserted-by":"crossref","first-page":"A76","DOI":"10.1016\/j.jval.2011.02.427","article-title":"Cost-effectiveness of tolterodine as treatment for overactive bladder (OAB) in adult mexican patients","volume":"14","author":"Arreola-Ornelas H","year":"2011","unstructured":"Arreola-Ornelas H, Rosado-Buzzo A, Garcia-Mollinedo M Cost-effectiveness of tolterodine as treatment for overactive bladder (OAB) in adult mexican patients. Value Health 14(3), A76 (2011).","journal-title":"Value Health"},{"issue":"1","key":"e_1_3_6_104_2","first-page":"S43","article-title":"Cardiovascular risk factors and lifestyles of older mexicans with cardiovascular events","volume":"62","author":"Camacho ME","year":"2014","unstructured":"Camacho ME, Saenz JL, McKey TA Cardiovascular risk factors and lifestyles of older mexicans with cardiovascular events. J. Am. Geriatr. Soc. 62(Suppl. 1), S43 (2014).","journal-title":"J. Am. Geriatr. Soc."},{"issue":"4","key":"e_1_3_6_105_2","first-page":"536","article-title":"Chronic kidney disease mortality and its relation to diabetes in Mexico","volume":"34","author":"Aldrete-Velasco JA","year":"2018","unstructured":"Aldrete-Velasco JA, Chiquete E, Rodriguez-Garcia JA Chronic kidney disease mortality and its relation to diabetes in Mexico. Med. Interna Mex. 34(4), 536\u2013550 (2018).","journal-title":"Med. Interna Mex."},{"issue":"5","key":"e_1_3_6_106_2","first-page":"496","article-title":"Evaluation of the characteristics of aortic dissection by computed angio-tomography in the Mexican population","volume":"88","author":"Burboa-Noriega L","year":"2018","unstructured":"Burboa-Noriega L, Burboa-Noriega J, Cristancho-Rojas C Evaluation of the characteristics of aortic dissection by computed angio-tomography in the Mexican population. Arch. Cardiol. Mex. 88(5), 496\u2013502 (2018).","journal-title":"Arch. Cardiol. Mex."},{"issue":"4","key":"e_1_3_6_107_2","first-page":"344","article-title":"[Medical and surgical health care for congenital heart disease: a panoramic vision of the reality in Mexico. Inquiry 2009]","volume":"63","author":"Calder\u00f3n-Colmenero J","year":"2011","unstructured":"Calder\u00f3n-Colmenero J, De-la-Llata M, Vizca\u00edno A [Medical and surgical health care for congenital heart disease: a panoramic vision of the reality in Mexico. Inquiry 2009]. Rev. Invest. Clin. 63(4), 344\u2013352 (2011).","journal-title":"Rev. Invest. Clin."},{"issue":"5","key":"e_1_3_6_108_2","first-page":"403","article-title":"[Epidemiology of glomerular disease in adults: a database review]","volume":"150","author":"Ch\u00e1vez Valencia V","year":"2014","unstructured":"Ch\u00e1vez Valencia V, Orizaga de La Cruz C, Becerra Fuentes JG [Epidemiology of glomerular disease in adults: a database review]. Gac. Med. Mex. 150(5), 403\u2013408 (2014).","journal-title":"Gac. Med. Mex."},{"issue":"4","key":"e_1_3_6_109_2","first-page":"213","article-title":"Prevalence of extensively drug-resistant bacteria isolated in urine cultures over an 8-year period at a secondary care hospital in Mexico","volume":"76","author":"Chavolla-Canal AJ","year":"2016","unstructured":"Chavolla-Canal AJ, Gonzalez-Mercado MG, Ruiz-Larios OA. Prevalence of extensively drug-resistant bacteria isolated in urine cultures over an 8-year period at a secondary care hospital in Mexico. Rev. Mex. Urol. 76(4), 213\u2013217 (2016).","journal-title":"Rev. Mex. Urol."},{"issue":"3","key":"e_1_3_6_110_2","first-page":"206","article-title":"[Non-traumatic spontaneous retroperitoneal bleeding: the effect of an early and accurate diagnosis]","volume":"83","author":"Sierra-D\u00edaz E","year":"2015","unstructured":"Sierra-D\u00edaz E, Belmonte-Hern\u00e1ndez MV, Villanueva-P\u00e9rez MA [Non-traumatic spontaneous retroperitoneal bleeding: the effect of an early and accurate diagnosis]. Cir. Cir. 83(3), 206\u2013210 (2015).","journal-title":"Cir. Cir."},{"issue":"3","key":"e_1_3_6_111_2","first-page":"192","article-title":"[Risk of drug interactions. Combinations of drugs associated with ventricular arrhythmias]","volume":"54","author":"Viramontes-Madrid JL","year":"2002","unstructured":"Viramontes-Madrid JL, Jerjes-S\u00e1nchez C, Pelaez-Ballestas I [Risk of drug interactions. Combinations of drugs associated with ventricular arrhythmias]. Rev. Invest. Clin. 54(3), 192\u2013197 (2002).","journal-title":"Rev. Invest. Clin."},{"issue":"2","key":"e_1_3_6_112_2","first-page":"140","article-title":"[Future status of ischaemic heart disease in the state of San Luis Potos\u00ed: a predictive dynamic model]","volume":"88","author":"Gayt\u00e1n-Hern\u00e1ndez D","year":"2018","unstructured":"Gayt\u00e1n-Hern\u00e1ndez D, D\u00edaz-Oviedo A, Gallegos-Garc\u00eda V [Future status of ischaemic heart disease in the state of San Luis Potos\u00ed: a predictive dynamic model]. Arch. Cardiol. Mex. 88(2), 140\u2013147 (2018).","journal-title":"Arch. Cardiol. Mex."},{"issue":"6","key":"e_1_3_6_113_2","doi-asserted-by":"crossref","first-page":"e7288","DOI":"10.5867\/medwave.2018.06.7288","article-title":"Demographic and clinical characteristics, and adverse reactions of people with overweight and obesity consumers of orlistat, attended by a call center (2009\u20132017)","volume":"17","author":"Rizo Trevi\u00f1o S","year":"2018","unstructured":"Rizo Trevi\u00f1o S. Demographic and clinical characteristics, and adverse reactions of people with overweight and obesity consumers of orlistat, attended by a call center (2009\u20132017). Medwave 17(6), e7288 (2018).","journal-title":"Medwave"},{"issue":"5","key":"e_1_3_6_114_2","doi-asserted-by":"crossref","first-page":"345","DOI":"10.2188\/jea.JE20140137","article-title":"Secondary data analysis of epidemiology in Asia","volume":"24","author":"Murakami Y","year":"2014","unstructured":"Murakami Y. Secondary data analysis of epidemiology in Asia. J. Epidemiol. 24(5), 345\u2013346 (2014).","journal-title":"J. Epidemiol."},{"issue":"23","key":"e_1_3_6_115_2","doi-asserted-by":"crossref","first-page":"2161","DOI":"10.1056\/NEJMp1401111","article-title":"Learning from big health care data","volume":"370","author":"Schneeweiss S","year":"2014","unstructured":"Schneeweiss S. Learning from big health care data. N. Engl. J. Med. 370(23), 2161\u20132163 (2014).","journal-title":"N. Engl. J. Med."},{"issue":"3","key":"e_1_3_6_116_2","doi-asserted-by":"crossref","first-page":"e0249088","DOI":"10.1371\/journal.pone.0249088","article-title":"Research using population-based administration data integrated with longitudinal data in child protection settings: a systematic review","volume":"16","author":"Chikwava F","year":"2021","unstructured":"Chikwava F, Cordier R, Ferrante A, O'Donnell M, Speyer R, Parsons L. Research using population-based administration data integrated with longitudinal data in child protection settings: a systematic review. PLoS ONE 16(3), e0249088 (2021).","journal-title":"PLoS ONE"},{"issue":"1","key":"e_1_3_6_117_2","doi-asserted-by":"crossref","first-page":"e56","DOI":"10.17269\/cjph.107.5244","article-title":"Quality of administrative health databases in Canada: a scoping review","volume":"107","author":"Hinds A","year":"2016","unstructured":"Hinds A, Lix LM, Smith M, Quan H, Sanmartin C. Quality of administrative health databases in Canada: a scoping review. Can. J. Public Health 107(1), e56\u2013e61 (2016).","journal-title":"Can. J. Public Health"},{"issue":"6","key":"e_1_3_6_118_2","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1017\/S1047951118000446","article-title":"Administrative health databases for addressing emerging issues in adults with CHD: a systematic review","volume":"28","author":"Cohen S","year":"2018","unstructured":"Cohen S, Gilutz H, Marelli AJ Administrative health databases for addressing emerging issues in adults with CHD: a systematic review. Cardiol. Young 28(6), 844\u2013853 (2018).","journal-title":"Cardiol. Young"},{"issue":"3","key":"e_1_3_6_119_2","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1200\/JOP.2015.004267","article-title":"Transforming data from information to quality improvement: a panel discussion with electronic health record vendors","volume":"11","author":"Blayney DW","year":"2015","unstructured":"Blayney DW. Transforming data from information to quality improvement: a panel discussion with electronic health record vendors. J. Oncol. Pract. 11(3), 174\u2013175 (2015).","journal-title":"J. Oncol. Pract."},{"key":"e_1_3_6_120_2","doi-asserted-by":"publisher","DOI":"10.1007\/s41669-020-00221-y"},{"issue":"10026","key":"e_1_3_6_121_2","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1016\/S0140-6736(16)00619-X","article-title":"Public health and international drug policy","volume":"387","author":"Csete J","year":"2016","unstructured":"Csete J, Kamarulzaman A, Kazatchkine M Public health and international drug policy. Lancet 387(10026), 1427\u20131480 (2016).","journal-title":"Lancet"},{"key":"e_1_3_6_122_2","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/s12961-016-0089-0","article-title":"Enhancing evidence informed policymaking in complex health systems: lessons from multi-site collaborative approaches","volume":"14","author":"Langlois EV","year":"2016","unstructured":"Langlois EV, Becerril Montekio V, Young T, Song K, Alcalde-Rabanal J, Tran N. Enhancing evidence informed policymaking in complex health systems: lessons from multi-site collaborative approaches. Health Res. Policy Syst. 14, 20 (2016).","journal-title":"Health Res. Policy Syst."}],"container-title":["Journal of Comparative Effectiveness Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/becarispublishing.com\/doi\/pdf\/10.57264\/cer-2025-0160","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T12:53:55Z","timestamp":1772801635000},"score":1,"resource":{"primary":{"URL":"https:\/\/becarispublishing.com\/doi\/10.57264\/cer-2025-0160"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":120,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,3]]}},"alternative-id":["10.57264\/cer-2025-0160"],"URL":"https:\/\/doi.org\/10.57264\/cer-2025-0160","relation":{},"ISSN":["2042-6305","2042-6313"],"issn-type":[{"value":"2042-6305","type":"print"},{"value":"2042-6313","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3]]},"article-number":"e250160"}}